Nature Communications (Sep 2023)

Acetylation reprograms MITF target selectivity and residence time

  • Pakavarin Louphrasitthiphol,
  • Alessia Loffreda,
  • Vivian Pogenberg,
  • Sarah Picaud,
  • Alexander Schepsky,
  • Hans Friedrichsen,
  • Zhiqiang Zeng,
  • Anahita Lashgari,
  • Benjamin Thomas,
  • E. Elizabeth Patton,
  • Matthias Wilmanns,
  • Panagis Filippakopoulos,
  • Jean-Philippe Lambert,
  • Eiríkur Steingrímsson,
  • Davide Mazza,
  • Colin R. Goding

DOI
https://doi.org/10.1038/s41467-023-41793-7
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 15

Abstract

Read online

Abstract The ability of transcription factors to discriminate between different classes of binding sites associated with specific biological functions underpins effective gene regulation in development and homeostasis. How this is achieved is poorly understood. The microphthalmia-associated transcription factor MITF is a lineage-survival oncogene that plays a crucial role in melanocyte development and melanoma. MITF suppresses invasion, reprograms metabolism and promotes both proliferation and differentiation. How MITF distinguishes between differentiation and proliferation-associated targets is unknown. Here we show that compared to many transcription factors MITF exhibits a very long residence time which is reduced by p300/CBP-mediated MITF acetylation at K206. While K206 acetylation also decreases genome-wide MITF DNA-binding affinity, it preferentially directs DNA binding away from differentiation-associated CATGTG motifs toward CACGTG elements. The results reveal an acetylation-mediated switch that suppresses differentiation and provides a mechanistic explanation of why a human K206Q MITF mutation is associated with Waardenburg syndrome.